Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CONMED Co. stock logo
CNMD
CONMED
$56.77
-1.6%
$55.30
$46.00
$78.58
$1.76B1.19444,140 shs284,051 shs
Enovis Co. stock logo
ENOV
Enovis
$31.32
-2.3%
$34.00
$29.32
$51.00
$1.79B1.79793,661 shs974,234 shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$82.17
+1.4%
$83.86
$71.42
$109.58
$1.86B0.86167,953 shs166,962 shs
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
$39.73
-0.9%
$36.10
$21.77
$81.56
$443.07M1.33488,876 shs698,780 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CONMED Co. stock logo
CNMD
CONMED
0.00%+2.52%-1.30%-2.47%-25.73%
Enovis Co. stock logo
ENOV
Enovis
0.00%-0.92%-11.09%-17.21%-37.70%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
0.00%+0.95%+4.41%-10.84%+4.17%
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
0.00%-10.36%+9.87%+2.16%+35.46%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CONMED Co. stock logo
CNMD
CONMED
3.8432 of 5 stars
1.21.02.54.33.00.83.1
Enovis Co. stock logo
ENOV
Enovis
2.6014 of 5 stars
3.41.00.00.02.41.71.9
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.5627 of 5 stars
2.21.03.30.03.12.51.3
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
2.8955 of 5 stars
3.52.00.00.02.62.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CONMED Co. stock logo
CNMD
CONMED
2.40
Hold$62.209.56% Upside
Enovis Co. stock logo
ENOV
Enovis
2.80
Moderate Buy$58.0085.19% Upside
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.33
Hold$97.8319.06% Upside
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
3.00
Buy$71.0078.71% Upside

Current Analyst Ratings Breakdown

Latest SMLR, LMAT, ENOV, and CNMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2025
Enovis Co. stock logo
ENOV
Enovis
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$75.00 ➝ $70.00
5/9/2025
Enovis Co. stock logo
ENOV
Enovis
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$62.00 ➝ $55.00
5/9/2025
Enovis Co. stock logo
ENOV
Enovis
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$64.00 ➝ $57.00
5/1/2025
CONMED Co. stock logo
CNMD
CONMED
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$70.00 ➝ $58.00
5/1/2025
CONMED Co. stock logo
CNMD
CONMED
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$70.00 ➝ $57.00
5/1/2025
CONMED Co. stock logo
CNMD
CONMED
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$91.00 ➝ $61.00
4/28/2025
CONMED Co. stock logo
CNMD
CONMED
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$75.00 ➝ $55.00
4/9/2025
Enovis Co. stock logo
ENOV
Enovis
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$64.00 ➝ $64.00
4/2/2025
Enovis Co. stock logo
ENOV
Enovis
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$64.00 ➝ $64.00
(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CONMED Co. stock logo
CNMD
CONMED
$1.32B1.33$6.22 per share9.13$31.15 per share1.82
Enovis Co. stock logo
ENOV
Enovis
$2.15B0.83$4.57 per share6.86$62.66 per share0.50
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$226.26M8.21$1.45 per share56.52$13.38 per share6.14
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
$49.23M9.00$2.34 per share16.95$10.45 per share3.80
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CONMED Co. stock logo
CNMD
CONMED
$132.42M$3.8013.3911.201.8310.13%14.31%5.64%7/30/2025 (Estimated)
Enovis Co. stock logo
ENOV
Enovis
-$33.26M-$13.95N/A9.82N/A-5.95%4.39%2.80%8/6/2025 (Estimated)
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$30.10M$1.9844.9037.872.2219.40%13.15%11.47%7/30/2025 (Estimated)
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
$20.58M-$2.618.09N/A72.65%50.77%47.04%8/4/2025 (Estimated)

Latest SMLR, LMAT, ENOV, and CNMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
N/A-$0.76N/A-$6.74N/A$8.84 million
5/8/2025Q1 2025
Enovis Co. stock logo
ENOV
Enovis
$0.74$0.81+$0.07-$0.98$558.80 million$558.83 million
5/1/2025Q1 2025
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.50$0.48-$0.02$0.48$57.61 million$59.87 million
4/30/2025Q1 2025
CONMED Co. stock logo
CNMD
CONMED
$0.81$0.95+$0.14$0.19$313.38 million$321.26 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CONMED Co. stock logo
CNMD
CONMED
$0.801.41%N/A21.05%N/A
Enovis Co. stock logo
ENOV
Enovis
N/AN/AN/AN/AN/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.800.97%+13.30%40.40%14 Years
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
N/AN/AN/AN/AN/A

Latest SMLR, LMAT, ENOV, and CNMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/21/2025
CONMED Co. stock logo
CNMD
CONMED
quarterly$0.201.34%6/13/20256/13/20257/3/2025
4/29/2025
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
quarterly$0.201%5/15/20255/15/20255/29/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CONMED Co. stock logo
CNMD
CONMED
0.94
2.30
1.06
Enovis Co. stock logo
ENOV
Enovis
0.40
2.27
1.12
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
N/A
7.74
5.52
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
N/A
3.14
3.09

Institutional Ownership

CompanyInstitutional Ownership
CONMED Co. stock logo
CNMD
CONMED
N/A
Enovis Co. stock logo
ENOV
Enovis
98.45%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
84.64%
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
49.37%

Insider Ownership

CompanyInsider Ownership
CONMED Co. stock logo
CNMD
CONMED
3.10%
Enovis Co. stock logo
ENOV
Enovis
2.70%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
9.50%
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
30.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
CONMED Co. stock logo
CNMD
CONMED
4,10030.94 million28.81 millionOptionable
Enovis Co. stock logo
ENOV
Enovis
6,80057.12 million55.49 millionOptionable
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
49022.59 million20.06 millionOptionable
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
12011.15 million6.47 millionNot Optionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CONMED stock logo

CONMED NYSE:CNMD

$56.77 -0.92 (-1.59%)
Closing price 05/30/2025 03:59 PM Eastern
Extended Trading
$56.75 -0.02 (-0.04%)
As of 07:49 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Enovis stock logo

Enovis NYSE:ENOV

$31.32 -0.73 (-2.28%)
Closing price 05/30/2025 03:59 PM Eastern
Extended Trading
$31.30 -0.02 (-0.06%)
As of 07:48 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

LeMaitre Vascular stock logo

LeMaitre Vascular NASDAQ:LMAT

$82.17 +1.10 (+1.36%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$82.20 +0.03 (+0.04%)
As of 07:48 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Semler Scientific stock logo

Semler Scientific NASDAQ:SMLR

$39.73 -0.35 (-0.87%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$40.26 +0.53 (+1.32%)
As of 08:34 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.